+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Variability in human cytochrome P450 paclitaxel metabolism

Variability in human cytochrome P450 paclitaxel metabolism

Journal of Pharmacology and Experimental Therapeutics 275(2): 566-575

Formation of 6 alpha-hydroxypaclitaxel has been described as the primary biotransformation pathway for paclitaxel in vitro and in vivo, with additional formation of two other "minor" metabolites. Using a large group (n = 49) of human liver microsomes, and P450s heterologously expressed in cell lines, our aims were to elucidate the P450s responsible for and investigate variability in paclitaxel metabolite formation. Four metabolites of paclitaxel (6 alpha-hydroxypaclitaxel, metabolites B, C and A) were formed in vitro, via CYP2C8, 3A4, 3A4 and both 2C8 and 3A4, respectively. Although 6 alpha-hydroxypaclitaxel was predominant in the majority of livers, metabolites B and C (formed by CYP3A4) were predominant in 11/49 and 2/49 livers, respectively. Predominance of metabolite B over 6 alpha-hydroxypaclitaxel was more likely in liver microsomes from donors known to be exposed to phenobarbital (P = .009), and tended to be more likely in diseased vs. normal livers (P = .047). Formation rates for 6 alpha-hydroxypaclitaxel, A, B, and C were lower in diseased liver vs. normal liver (P < .001). Rates of formation of metabolites B and C were highly correlated with each other (r2 = .91; P < .001) and with midazolam 4-hydroxylation (r2 = .87 & 0.86, respectively; P < .001). Inhibitor experiments suggest that typical CYP3A substrates/inhibitors (e.g., cyclosporin, epipodophyllotoxins) may significantly interact with paclitaxel in vivo. In a single patient in whom plasma samples were measured on two occasions, metabolite A (the dihydroxylate) was predominant, and systemic clearance of paclitaxel was lower in a course administered 1 day vs. 6 wk after a course of fluconazole therapy. We report that 6 alpha-hydroxypaclitaxel, formed via CYP2C8, is not the predominant paclitaxel metabolite in all individuals, and that CYP3A4 catalytic activity is important to overall paclitaxel metabolism in humans.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 009714946

Download citation: RISBibTeXText

PMID: 7473140

Related references

Characterization of human cytochrome P450 isoforms involved in the metabolism of 7-epi-paclitaxel. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 39(4): 283-292, 2009

Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicity. Pharmacogenomics 16(9): 929-937, 2016

Comparative metabolism of the tobacco-specific nitrosamines 4- -1- -1-butanone and 4- -1- -1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13. Drug Metabolism & Disposition 31(10): 1199-1202, October, 2003

Nefiracetam metabolism by human liver microsomes: Role of cytochrome P450 3A4 and cytochrome P450 1A2 in 5-hydroxynefiracetam formation. Journal of Pharmacy & Pharmacology 53(6): 795-804, June, 2001

Metabolism of the tobacco-specific lung carcinogens, NNK and NNAL by rat cytochrome P450 2A3 and human cytochrome P450 2A13. Drug Metabolism Reviews 35(Supplement 2): 190, 2003

Genetically engineered bacterial cells co-expressing human cytochrome P450 with NADPH-cytochrome P450 reductase: prediction of metabolism and toxicity of drugs in humans. Drug Metabolism and Pharmacokinetics 17(1): 1-22, 2004

Comparison of in vitro metabolism of ticlopidine by human cytochrome P450 2B6 and rabbit cytochrome P450 2B4. Drug Metabolism and Disposition: the Biological Fate of Chemicals 39(3): 539-550, 2011

Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs. Drug Metabolism and Pharmacokinetics 20(6): 478-484, 2006

Comparative effects of rabeprazole and omeprazole on the inducibility of cytochrome P450-1A and cytochrome P450-3A isoenzymes in human hepatocytes, and effects on cyclosporin metabolism in human liver microsomes. Clinical Drug Investigation 20(4): 245-254, October, 2000

Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(2): 146-162, 2010

Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chemico-Biological Interactions 185(3): 163-173, 2010

Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4. Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(3): 229-233, 1998

Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(9): 1072-1080, 1997